Saeterdal I, Gjertsen M K, Straten P, Eriksen J A, Gaudernack G
Department of Immunology, The Norwegian Radium Hospital, University of Oslo, Montebello.
Cancer Immunol Immunother. 2001 Nov;50(9):469-76. doi: 10.1007/s002620100222.
Microsatellite instability (MSI) is recognised as genome-wide alterations in repetitive DNA sequences caused by defects in the DNA mismatch repair machinery. Such mutation patterns have been found in almost all analysed malignancies from patients with hereditary non-polyposis colorectal cancer, and in approximately 15% of sporadic colorectal cancers. In cancers with the MSI phenotype, microsatellite-like sequences in coding regions of various cancer-related genes, including transforming growth factor beta receptor type II (TGF betaRII), are targets for mutations. The TGF betaRII gene harbours a 10-bp polyadenine tract, and mutations within this region are found in 90% of colorectal cancers with MSI. The frameshift mutations result in new amino acid sequences in the C-terminal part of the proteins, prematurely terminating where a novel stop codon appears. In this study we have defined new cytotoxic T lymphocyte (CTL) epitope (RLSSCVPVA), carrying a good HLA-A*0201 binding motif, and resulting from the most common frameshift mutation in TGF betaRII. A CTL line and several CTL clones were generated from an HLA-A2+ normal donor by repeated stimulation of T cells with dendritic cells pulsed with the peptide. One of the CTL clones was able to kill an HLA-A2+ colon cancer cell line harbouring mutant TGF betaRII. This epitope may be a valuable component in cancer vaccines directed at MSI-positive carcinomas.
微卫星不稳定性(MSI)被认为是由DNA错配修复机制缺陷导致的全基因组重复DNA序列改变。在遗传性非息肉病性结直肠癌患者的几乎所有分析过的恶性肿瘤中,以及约15%的散发性结直肠癌中都发现了这种突变模式。在具有MSI表型的癌症中,包括转化生长因子β受体II型(TGFβRII)在内的各种癌症相关基因编码区的微卫星样序列是突变靶点。TGFβRII基因含有一个10个碱基的聚腺苷酸序列,在90%的MSI结直肠癌中可发现该区域内的突变。移码突变导致蛋白质C末端出现新的氨基酸序列,并在出现新的终止密码子处提前终止。在本研究中,我们确定了一种新的细胞毒性T淋巴细胞(CTL)表位(RLSSCVPVA),它具有良好的HLA - A*0201结合基序,由TGFβRII中最常见的移码突变产生。通过用该肽脉冲处理的树突状细胞反复刺激T细胞,从一名HLA - A2 +正常供体中产生了一条CTL细胞系和几个CTL克隆。其中一个CTL克隆能够杀死携带突变TGFβRII的HLA - A2 +结肠癌细胞系。该表位可能是针对MSI阳性癌的癌症疫苗中的一个有价值的成分。